Primary PCI versus pharmacoinvasive strategy for ST elevation myocardial infarction

BACKGROUND: The rationale for pharmacoinvasive strategy is that many patients have a persistent reduction in flow in the infarct-related artery. The aim of the present study is to assess safety and efficacy of pharmacoinvasive strategy using streptokinase compared to primary PCI and ischemia driven...

Descripción completa

Detalles Bibliográficos
Autores principales: Helal, Ayman M., Shaheen, Sameh M., Elhammady, Walid A., Ahmed, Mohamed I., Abdel-Hakim, Ahmed S., Allam, Lamyaa E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6205251/
https://www.ncbi.nlm.nih.gov/pubmed/30402534
http://dx.doi.org/10.1016/j.ijcha.2018.10.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6205251/
https://www.ncbi.nlm.nih.gov/pubmed/30402534
http://dx.doi.org/10.1016/j.ijcha.2018.10.006

Ejemplares similares